-
公开(公告)号:US5084582A
公开(公告)日:1992-01-28
申请号:US635524
申请日:1991-01-18
申请人: Jean-Pierre Genet , Dominique Pons , Sylvain Juge
发明人: Jean-Pierre Genet , Dominique Pons , Sylvain Juge
IPC分类号: C07D303/38 , C07D303/48
CPC分类号: C07D303/38 , C07D303/48
摘要: The invention relates to a method of oxidizing epoxyalcohols, in a medium containing an organic solvent and water, by means of a solid oxidizing compound, in the presence of a catalyst based on a ruthenium salt. The proportion of water relative to that of organic solvent is sufficiently small for at least the major part of the oxidizing compound to remain in the solid state in the reaction medium, which is heterogeneous.
摘要翻译: PCT No.PCT / FR89 / 00320 Sec。 371日期1991年1月18日 102(e)日期1991年1月18日PCT Filed Jun.23,1989 PCT Pub。 公开号WO90 / 00167 日本1990年1月11日。本发明涉及在基于钌盐的催化剂存在下,通过固体氧化性化合物在含有有机溶剂和水的介质中氧化环氧醇的方法。 相对于有机溶剂的水的比例足够小,至少大部分氧化性化合物在反应介质中保持固态,这是异质的。
-
2.
公开(公告)号:US07534805B2
公开(公告)日:2009-05-19
申请号:US10557303
申请日:2004-05-26
IPC分类号: A61K31/4174 , C07D233/60
CPC分类号: C07D233/64 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12
摘要: Novel imidazole compounds of the formula wherein the substituents are as defined in the application having antitumoral activity and use thereof.
摘要翻译: 具有下式的新型咪唑化合物其中取代基如本申请中所定义的具有抗肿瘤活性及其用途。
-
3.Novel imidazole derivatives, their preparation and their use as medicaments 失效
标题翻译: 新型咪唑衍生物,其制备及其作为药物的用途公开(公告)号:US20070066542A1
公开(公告)日:2007-03-22
申请号:US10557303
申请日:2004-05-26
IPC分类号: A61K31/70 , C07D233/54 , A61K31/4164
CPC分类号: C07D233/64 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12
摘要: Novel imidazole compounds of the formula wherein the substituents are as defined in the application having antitumoral activity and use thereof.
摘要翻译: 具有下式的新型咪唑化合物其中取代基如本申请中所定义的具有抗肿瘤活性及其用途。
-
公开(公告)号:US08188133B2
公开(公告)日:2012-05-29
申请号:US12298757
申请日:2007-04-26
IPC分类号: A61K31/33 , C07D233/58
CPC分类号: C07D233/64
摘要: The invention concerns novel imidazole derivatives of general formula (I), wherein Z′ and Z represent different variable groups. Said products have an antitumoral activity. The invention also concerns pharmaceutical compositions containing said products and their use for preparing antitumoral medicine.
摘要翻译: 本发明涉及通式(I)的新型咪唑衍生物,其中Z'和Z代表不同的可变基团。 所述产品具有抗肿瘤活性。 本发明还涉及含有所述产品的药物组合物及其用于制备抗肿瘤药物的用途。
-
5.Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same 失效
标题翻译: 脒衍生物,其制备和作为药物的应用和含有它们的药物组合物公开(公告)号:US06653312B1
公开(公告)日:2003-11-25
申请号:US09787467
申请日:2001-03-16
申请人: Serge Auvin , Pierre-Etienne Chabrier de Lassauniere , Jeremiah Harnett , Dominique Pons , Gérard Ulibarri
发明人: Serge Auvin , Pierre-Etienne Chabrier de Lassauniere , Jeremiah Harnett , Dominique Pons , Gérard Ulibarri
IPC分类号: C07D33336
CPC分类号: C07D409/12 , C07C217/84 , C07D333/20 , C07D333/36 , C07D333/38 , C07D409/14 , C07D417/12 , C07D473/08
摘要: Amidine compounds of the formula wherein the substituents are defined as in the application useful as NO-synthase enzyme inhibitors.
摘要翻译: 取代基中的取代基的脒化合物定义为可用作NO-合酶酶抑制剂的应用。
-
6.Derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them 失效
标题翻译: 脒的衍生物,它们的制备,它们作为药物的用途以及含有它们的药物组合物公开(公告)号:US07473779B2
公开(公告)日:2009-01-06
申请号:US10662183
申请日:2003-09-12
申请人: Serge Auvin , Pierre-Etienne Chabrier de Lassauniere , Jeremiah Harnett , Dominique Pons , Gérard Ulibarri
发明人: Serge Auvin , Pierre-Etienne Chabrier de Lassauniere , Jeremiah Harnett , Dominique Pons , Gérard Ulibarri
IPC分类号: A01N43/00 , A01N43/40 , A01N43/36 , A01N37/52 , A61K31/397 , A61K31/55 , A61K31/445 , A61K31/40 , A61K31/155 , C07D223/04 , C07D211/26 , C07D211/28 , C07D207/46 , C07D295/04 , C07D205/00 , C07C257/00
CPC分类号: C07D409/12 , C07C217/84 , C07D333/20 , C07D333/36 , C07D333/38 , C07D409/14 , C07D417/12 , C07D473/08
摘要: Novel derivatives of amidines of formula wherein the substituents are defined as in the specification which are useful for inhibiting activity on NO-synthase enzymes producing nitrogen mono oxide and/or trapping the reactive oxygen species (ROS) making them useful for treating various diseases.
摘要翻译: 式脒的新型衍生物,其中取代基如说明书中所定义,其可用于抑制产生氮一氧化物的NO合成酶和/或捕获活性氧(ROS)的活性,使得它们可用于治疗各种疾病。
-
7.TRIAMINOPYRIMIDINE CYCLOBUTENEDIONE DERIVATIVES USED AS PHOSPHATASE CDC25 INHIBITORS 审中-公开
标题翻译: 用作磷酸酶CDC25抑制剂的三亚氨基嘧啶环化酶衍生物公开(公告)号:US20100173910A1
公开(公告)日:2010-07-08
申请号:US12668999
申请日:2008-07-10
申请人: Anne-Marie Liberatore , Dominique Pons , Dennis Bigg , Grégorie Prevost , Marie-Christine Brezak Pannetier
发明人: Anne-Marie Liberatore , Dominique Pons , Dennis Bigg , Grégorie Prevost , Marie-Christine Brezak Pannetier
IPC分类号: A61K31/5377 , A61P35/00 , C07D403/12 , A61K31/506 , C07D413/12
CPC分类号: C07D239/50 , C07D213/74 , C07D257/04 , C07D317/66 , C07D401/12 , C07D403/12 , C07D405/12
摘要: The present invention relates to triaminopyrimidine derivatives of formula (I) where Y, R3, W, R4a, R5a, R4b, R5b, n and m are variable. These compounds have CDC25 phosphatase-inhibiting activity and can therefore be used as drugs in diseases in which CDC25 phosphatases are involved. The invention also relates to pharmaceutical compositions containing said products and methods of using the drug.
摘要翻译: 本发明涉及式(I)的三氨基嘧啶衍生物,其中Y,R3,W,R4a,R5a,R4b,R5b,n和m是可变的。 这些化合物具有CDC25磷酸酶抑制活性,因此可用作涉及CDC25磷酸酶的疾病中的药物。 本发明还涉及含有所述产品的药物组合物和使用该药物的方法。
-
8.New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them 失效
标题翻译: 脒的新衍生物,其制备方法,药物用途以及含有它们的药物组合物公开(公告)号:US20060084667A1
公开(公告)日:2006-04-20
申请号:US11250783
申请日:2005-10-14
申请人: Serge Auvin , Pierre-Etienne Chabrier de Lassauniere , Jeremiah Harnett , Dominique Pons , Gerard Ulibarri
发明人: Serge Auvin , Pierre-Etienne Chabrier de Lassauniere , Jeremiah Harnett , Dominique Pons , Gerard Ulibarri
IPC分类号: A61K31/522 , A61K31/506 , A61K31/44 , A61K31/137 , C07C217/18 , C07D473/02 , C07D403/14
CPC分类号: C07D409/12 , C07C217/84 , C07D333/20 , C07D333/36 , C07D333/38 , C07D409/14 , C07D417/12 , C07D473/08
摘要: Compounds of the formula wherein the substituents are as defined in the specification useful as intermediates.
摘要翻译: 下式的化合物,其中取代基如本说明书中所定义,可用作中间体。
-
9.New derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them 失效
标题翻译: 脒的新衍生物,其制备方法,药物用途以及含有它们的药物组合物公开(公告)号:US20050261269A1
公开(公告)日:2005-11-24
申请号:US10662183
申请日:2003-09-12
IPC分类号: C07D333/20 , A61K31/38 , A61K31/381 , A61K31/4045 , A61K31/427 , A61K31/4433 , A61K31/4436 , A61K31/4709 , A61K31/495 , A61K31/506 , A61K31/52 , A61K31/5377 , A61P1/04 , A61P3/10 , A61P9/00 , A61P9/10 , A61P9/12 , A61P11/00 , A61P11/06 , A61P17/06 , A61P19/02 , A61P21/00 , A61P25/00 , A61P25/14 , A61P25/28 , A61P25/30 , A61P27/16 , A61P29/00 , A61P31/12 , A61P31/18 , A61P35/00 , A61P37/06 , C07D333/36 , C07D333/38 , C07D409/12 , C07D409/14 , C07D417/12 , C07D473/08 , A61K31/397 , A61K31/155 , A61K31/40 , A61K31/445 , A61K31/55
CPC分类号: C07D409/12 , C07C217/84 , C07D333/20 , C07D333/36 , C07D333/38 , C07D409/14 , C07D417/12 , C07D473/08
摘要: Novel derivatives of amidines of formula wherein the substituents are defined as in the specification which are useful for inhibiting activity on NO-synthase enzymes producing nitrogen mono oxide and/or trapping the reactive oxygen species (ROS) making them useful for treating various diseases.
摘要翻译: 式脒的新型衍生物,其中取代基如说明书中所定义,其可用于抑制产生氮一氧化物的NO合成酶和/或捕获活性氧(ROS)的活性,使得它们可用于治疗各种疾病。
-
10.Derivatives of 2-aminopyridines, their use as medicaments and pharmaceutical compositions containing them 失效
标题翻译: 2-氨基吡啶的衍生物,它们用作药物和含有它们的药物组合物公开(公告)号:US06727239B1
公开(公告)日:2004-04-27
申请号:US10405828
申请日:2003-04-02
申请人: Pierre-Etienne Chabrier de Lassauniere , Serge Auvin , Jerry Harnett , Dominique Pons , Gérard Ulibarri , Dennis Bigg
发明人: Pierre-Etienne Chabrier de Lassauniere , Serge Auvin , Jerry Harnett , Dominique Pons , Gérard Ulibarri , Dennis Bigg
IPC分类号: A61K3133
CPC分类号: C07K14/70575 , A01K67/0275 , A01K2217/05 , A01K2227/105 , A01K2267/03 , A01K2267/0325 , A01K2267/0368 , A01K2267/0381 , A61K2039/505 , C07D213/73 , C07D401/04 , C07D405/12 , C07K16/2875 , C07K16/2878 , C12N15/8509
摘要: A compound of the formula wherein the substituents are defined as in the specification and their pharmaceutically acceptable salts having NOS and ROS activity.
摘要翻译: 取代基中的取代基的化合物如说明书中所定义,并且其药学上可接受的盐具有NOS和ROS活性。
-
-
-
-
-
-
-
-
-